alcohol 9 as the limiting reagent only gave 56%, but this result
could certainly be improved upon. The use of a morpholine
amide 10 was also effective, but resulted in slightly diminished
yields compared with the Weinreb amide. Aldehydes are much
better electrophiles, and generated the 1,3-diol 12 in 92% yield
using phenylthio alcohol 9 as the limiting reagent. As expected,
the 1,3-diol was produced as a 1:1 mixture of diastereomers,
underscoring the need for an alternative strategy to introduce the
second stereogenic center. Using a modest excess (1.5 equiv) of
the phenylthio alcohol led to >90% yields of the desired aldol
product.
The aculeatins A-D have attracted significant attention
from synthetic chemists. They were isolated by Heilmann
from the rhizomes of Amomum aculeatum and were reported
to have significant antiprotozoal and antiplasmodial activity.14
In addition, they show low to submicromolar activity against
KB cell lines, and aculeatin A was found to be active against
MCF-7 (human breast cancer cells) using an in vivo hollow
fiber assay.15 The synthesis of racemic aculeatin A and B
was first reported by Wong,16 followed by enantioselective
syntheses by Marco.17 Synthesis of aculeatin D was first
reported by Baldwin.18 A number of other syntheses have
followed, all of which use a final phenol oxidation to
assemble the spirocyclic system.19 The aculeatins are inter-
esting synthetic targets and promising lead compounds in a
number of important therapeutic areas.
Figure 1. Structures and unified retrosynthetic analyses of aculeatins
A, B, and D.
the planned syntheses are Weinreb amide 16 and the optically
pure phenylthio alcohol 17.
The retrosynthetic analysis of the aculeatins is presented
in Figure 1. Aculeatin A and B are epimeric at the acetal
center, with A having the thermodynamically favored
configuration.17b Similarly, aculeatin D is thermodynamically
disfavored with respect to its C6 epimer. The final step is a
biomimetic cyclization using a dithiane in place of the C6
ketone.16 syn-1,3-Diol 13 is the precursor to A and B,
whereas anti-1,3-diol 14 is the precursor to aculeatin D. Both
diols share a common 2R-configuration (aculeatin number-
ing), and they will be derived from the common intermediate
15 by stereoselective reduction. The key building blocks for
Synthesis of the building blocks and an initial attempt at the
coupling reaction are shown in Scheme 3. Dithiane 18 was
Scheme 3
.
Synthesis of Aculeatin Precursors and an Attempted
Coupling Reaction
(13) The reaction was quenched with NH4Cl (aq) and did not show any
indication of racemization or retro-aldol side reactions. When the reaction
was quenched with MeOH-d4, we observed partial deuteration at the
positions adjacent to the ketone but not at the benzylic position. Traces of
retro-aldol product may be present, but apparently the forward aldol reaction
is unfavorable. In cases where the yields of 8 were modest, most of the
unreacted Weinreb amide 7 was recovered.
(14) (a) Heilmann, J.; Mayr, S.; Brun, R.; Rali, T.; Sticher, O. HelV.
Chim. Acta 2000, 83, 2939–2945. (b) Heilmann, J.; Brun, R.; Mayr, S.;
Rali, T.; Sticher, O. Phytochemistry 2001, 57, 1281–1285. (c) Salim, A. A.;
Su, B.-N.; Chai, H.-B.; Riswan, S.; Kardono, L. B. S.; Ruskandi, A.;
Farnsworth, N. R.; Swanson, S. M.; Kinghorn, A. D. Tetrahedron Lett.
2007, 48, 1849–1853.
(15) Chin, Y.-W.; Salim, A. A.; Su, B.-N.; Mi, Q.; Chai, H.-B.; Riswan,
S.; Kardono, L. B. S.; Ruskandi, A.; Farnsworth, N. R.; Swanson, S. M.;
Kinghorn, A. D. J. Nat. Prod. 2008, 71, 390–395.
prepared by Wong’s procedure.19d,16 Formation of the Weinreb
amide20 and protection of the phenol led to the coupling
partner 16. The optically pure hydroxy phenylthio alcohol
17 was prepared by epoxidation of 1-pentadecene, followed
by Jacobsen kinetic resolution.21 The thiophenol addition was
catalyzed by LiClO4 to give optically pure22 phenylthio
alcohol 17 in 34% overall yield. The initial coupling
experiments, using the conditions reported in Table 1, gave
none of the desired aldol product and returned both the Weinreb
(16) Wong, Y.-S. Chem. Commun. 2002, 686–687.
(17) (a) Falomir, E.; Alvarez-Bercedo, P.; Carda, M.; Marco, J. A.
Tetrahedron Lett. 2005, 46, 8407–8410. (b) Alvarez-Bercedo, P.; Falomir,
E.; Carda, M.; Marco, J. A. Tetrahedron 2006, 62, 9641–9649.
(18) Baldwin, J. E.; Adlington, R. M.; Sham, V. W. W.; Marquez, R.;
Bulger, P. G. Tetrahedron 2005, 61, 2353–2363.
(19) (a) Chandrasekhar, S.; Rambabu, C.; Shyamsunder, T. Tetrahedron
Lett. 2007, 48, 4683–4685. (b) Peuchmaur, M.; Wong, Y.-S. Synlett 2007,
2902–2906. (c) Peuchmaur, M.; Wong, Y.-S. J. Org. Chem. 2007, 72, 5374–
5379. (d) Peuchmaur, M.; Saidani, N.; Botte, C.; Marechal, E.; Vial, H.;
Wong, Y.-S. J. Med. Chem. 2008, 51, 4870–4873. (e) Ramana, C. V.;
Srinivas, B. J. Org. Chem. 2008, 73, 3915–3918. (f) Suresh, V.; Selvam,
J. J. P.; Rajesh, K.; Venkateswarlu, Y. Tetrahedron: Asymmetry 2008, 19,
1509–1513. (g) Zhen, Z.-B.; Gao, J.; Wu, Y. J. Org. Chem. 2008, 73, 7310–
7316.
(20) (a) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815–
3818. (b) Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.;
Dolling, U.-H.; Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461–5464.
4222
Org. Lett., Vol. 11, No. 18, 2009